An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment
In breast cancer, the immune infiltration of the tumour associates with clinical outcome. Here, the authors infer immune context based on gene expression data and identify a new independent subtype linked to pro-tumorigenic immune infiltration.
Guardado en:
Autores principales: | Xavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, Daniel Nebdal, Elin Borgen, Hege Oma Ohnstad, Jon Amund Kyte, Johan Vallon-Christersson, Marie Fongaard, Eldri Undlien Due, Lisa Gregusson Svartdal, My Anh Tu Sveli, Øystein Garred, OSBREAC, Arnoldo Frigessi, Kristine Kleivi Sahlberg, Therese Sørlie, Hege G. Russnes, Bjørn Naume, Vessela N. Kristensen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/77641556908e44e9aa2cd197f5b2e87b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DNA methylation at enhancers identifies distinct breast cancer lineages
por: Thomas Fleischer, et al.
Publicado: (2017) -
Compact city development: High ideals and emerging practices
por: Hege Hofstad
Publicado: (2012) -
Compact city development: High ideals and emerging practices
por: Hege Hofstad
Publicado: (2012) -
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro
por: Lisa Svartdal Normann, et al.
Publicado: (2021) -
miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors.
por: Espen Enerly, et al.
Publicado: (2011)